LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,109,717 | -18.1% | 218,787 | -1.4% | 0.00% | 0.0% |
| Q2 2023 | $16,004,974 | -3.8% | 221,983 | -1.8% | 0.00% | -20.0% |
| Q1 2023 | $16,632,137 | +9.7% | 226,103 | -0.3% | 0.01% | +25.0% |
| Q4 2022 | $15,155,984 | -7.9% | 226,886 | +18.7% | 0.00% | -20.0% |
| Q3 2022 | $16,453,000 | -15.8% | 191,071 | -12.8% | 0.01% | -16.7% |
| Q2 2022 | $19,541,000 | -10.7% | 219,034 | +12.6% | 0.01% | 0.0% |
| Q1 2022 | $21,886,000 | -32.2% | 194,566 | -6.9% | 0.01% | -25.0% |
| Q4 2021 | $32,284,000 | -14.6% | 209,012 | -23.0% | 0.01% | -20.0% |
| Q3 2021 | $37,807,000 | +21.2% | 271,371 | +14.2% | 0.01% | +25.0% |
| Q2 2021 | $31,182,000 | +1.9% | 237,687 | +18.4% | 0.01% | 0.0% |
| Q1 2021 | $30,608,000 | +58.8% | 200,768 | +3.6% | 0.01% | +33.3% |
| Q4 2020 | $19,275,000 | +9.5% | 193,816 | +5.0% | 0.01% | 0.0% |
| Q3 2020 | $17,595,000 | +0.8% | 184,582 | +18.3% | 0.01% | 0.0% |
| Q2 2020 | $17,454,000 | +59.7% | 156,041 | +3.8% | 0.01% | +20.0% |
| Q1 2020 | $10,930,000 | -47.3% | 150,296 | -24.5% | 0.01% | -16.7% |
| Q4 2019 | $20,749,000 | +596.3% | 198,956 | +564.7% | 0.01% | +500.0% |
| Q3 2019 | $2,980,000 | -92.9% | 29,933 | -91.8% | 0.00% | -90.9% |
| Q2 2019 | $41,895,000 | +698.5% | 367,013 | +779.3% | 0.01% | +450.0% |
| Q1 2019 | $5,247,000 | -69.6% | 41,740 | -67.2% | 0.00% | -71.4% |
| Q4 2018 | $17,257,000 | -85.8% | 127,172 | -71.3% | 0.01% | -81.6% |
| Q3 2018 | $121,477,000 | +98.5% | 442,556 | +49.8% | 0.04% | +90.0% |
| Q2 2018 | $61,195,000 | +67.7% | 295,387 | +33.7% | 0.02% | +42.9% |
| Q1 2018 | $36,491,000 | +26.6% | 220,942 | +5.0% | 0.01% | +40.0% |
| Q4 2017 | $28,826,000 | +6.1% | 210,517 | +5.5% | 0.01% | 0.0% |
| Q3 2017 | $27,168,000 | +2.9% | 199,544 | -8.3% | 0.01% | +25.0% |
| Q2 2017 | $26,407,000 | -30.0% | 217,518 | -39.0% | 0.01% | -33.3% |
| Q1 2017 | $37,741,000 | -9.9% | 356,585 | -13.5% | 0.01% | -14.3% |
| Q4 2016 | $41,883,000 | -17.3% | 412,190 | -17.0% | 0.01% | -17.6% |
| Q3 2016 | $50,673,000 | -10.0% | 496,498 | +5.2% | 0.02% | -19.0% |
| Q2 2016 | $56,310,000 | -8.0% | 472,113 | -17.4% | 0.02% | -16.0% |
| Q1 2016 | $61,204,000 | -23.7% | 571,509 | -22.8% | 0.02% | -21.9% |
| Q4 2015 | $80,239,000 | +3.0% | 740,076 | -18.6% | 0.03% | -3.0% |
| Q3 2015 | $77,872,000 | -18.5% | 909,186 | -4.0% | 0.03% | -10.8% |
| Q2 2015 | $95,554,000 | +7.5% | 947,020 | -17.9% | 0.04% | +8.8% |
| Q1 2015 | $88,912,000 | +83.7% | 1,153,053 | +26.8% | 0.03% | +78.9% |
| Q4 2014 | $48,390,000 | +28.7% | 909,422 | +13.7% | 0.02% | +26.7% |
| Q3 2014 | $37,594,000 | +10.7% | 800,045 | +46.8% | 0.02% | +15.4% |
| Q2 2014 | $33,955,000 | -21.4% | 545,116 | -15.1% | 0.01% | -27.8% |
| Q1 2014 | $43,173,000 | +53.7% | 641,797 | +20.2% | 0.02% | +63.6% |
| Q4 2013 | $28,086,000 | +33.6% | 533,964 | +9.9% | 0.01% | +22.2% |
| Q3 2013 | $21,021,000 | -3.7% | 485,704 | -16.8% | 0.01% | -10.0% |
| Q2 2013 | $21,824,000 | – | 583,529 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |